- Home
- SBCWW vs VRAX Comparison
SBCWW vs VRAX Comparison
Compare SBCWW & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCWW
- VRAX
- Stock Information
- Founded
- SBCWW N/A
- VRAX 2013
- Country
- SBCWW United States
- VRAX United Kingdom
- Employees
- SBCWW N/A
- VRAX N/A
- Industry
- SBCWW Medical/Nursing Services
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SBCWW Health Care
- VRAX Health Care
- Exchange
- SBCWW Nasdaq
- VRAX Nasdaq
- Market Cap
- SBCWW 19.1M
- VRAX 17.2M
- IPO Year
- SBCWW 2022
- VRAX 2022
- Fundamental
- Price
- SBCWW $0.16
- VRAX $1.94
- Analyst Decision
- SBCWW
- VRAX
- Analyst Count
- SBCWW 0
- VRAX 0
- Target Price
- SBCWW N/A
- VRAX N/A
- AVG Volume (30 Days)
- SBCWW N/A
- VRAX 1.4M
- Earning Date
- SBCWW N/A
- VRAX 11-06-2024
- Dividend Yield
- SBCWW N/A
- VRAX N/A
- EPS Growth
- SBCWW N/A
- VRAX N/A
- EPS
- SBCWW N/A
- VRAX N/A
- Revenue
- SBCWW N/A
- VRAX $156,419.00
- Revenue This Year
- SBCWW N/A
- VRAX $5,169.18
- Revenue Next Year
- SBCWW N/A
- VRAX $66.97
- P/E Ratio
- SBCWW N/A
- VRAX N/A
- Revenue Growth
- SBCWW N/A
- VRAX 1727.11
- 52 Week Low
- SBCWW N/A
- VRAX $0.60
- 52 Week High
- SBCWW N/A
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- SBCWW N/A
- VRAX 40.61
- Support Level
- SBCWW N/A
- VRAX $1.53
- Resistance Level
- SBCWW N/A
- VRAX $2.17
- Average True Range (ATR)
- SBCWW 0.00
- VRAX 0.27
- MACD
- SBCWW 0.00
- VRAX -0.06
- Stochastic Oscillator
- SBCWW 0.00
- VRAX 27.52
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.